- Home
- EVRI vs ARQT Comparison
EVRI vs ARQT Comparison
Compare EVRI & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVRI
- ARQT
- Stock Information
- Founded
- EVRI 1998
- ARQT 2016
- Country
- EVRI United States
- ARQT United States
- Employees
- EVRI N/A
- ARQT N/A
- Industry
- EVRI Services-Misc. Amusement & Recreation
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- EVRI Consumer Discretionary
- ARQT Health Care
- Exchange
- EVRI Nasdaq
- ARQT Nasdaq
- Market Cap
- EVRI 1.2B
- ARQT 1.1B
- IPO Year
- EVRI 2005
- ARQT 2020
- Fundamental
- Price
- EVRI $13.57
- ARQT $12.68
- Analyst Decision
- EVRI Hold
- ARQT Strong Buy
- Analyst Count
- EVRI 5
- ARQT 5
- Target Price
- EVRI $12.88
- ARQT $17.00
- AVG Volume (30 Days)
- EVRI 590.6K
- ARQT 2.1M
- Earning Date
- EVRI 02-27-2025
- ARQT 02-25-2025
- Dividend Yield
- EVRI N/A
- ARQT N/A
- EPS Growth
- EVRI N/A
- ARQT N/A
- EPS
- EVRI 0.15
- ARQT N/A
- Revenue
- EVRI $760,419,000.00
- ARQT $138,708,000.00
- Revenue This Year
- EVRI N/A
- ARQT $209.03
- Revenue Next Year
- EVRI $5.06
- ARQT $49.00
- P/E Ratio
- EVRI $90.87
- ARQT N/A
- Revenue Growth
- EVRI N/A
- ARQT 182.84
- 52 Week Low
- EVRI $6.37
- ARQT $3.11
- 52 Week High
- EVRI $13.65
- ARQT $16.20
- Technical
- Relative Strength Index (RSI)
- EVRI 61.25
- ARQT 43.06
- Support Level
- EVRI $13.47
- ARQT $13.10
- Resistance Level
- EVRI $13.65
- ARQT $14.36
- Average True Range (ATR)
- EVRI 0.05
- ARQT 0.99
- MACD
- EVRI 0.00
- ARQT -0.32
- Stochastic Oscillator
- EVRI 52.78
- ARQT 1.95
About EVRI Everi Holdings Inc.
Everi Holdings Inc provides entertainment and technology solutions for the casino, interactive, and gaming industry. It operates in two segments namely Games and Financial Technology Solutions (FinTech). Enveri Games provides gaming operators with gaming technology products and services which include gaming machines, slot machines, leased gaming equipment, and other products and services. Enveri FinTech provides gaming operators with financial technology products and services which include services and equipment that facilitate casino patron's to access cash at gaming facilities through automated teller machines, point of sale debit card purchases and others.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.